CHRONIC FATIGUE ILLNESS
For more go to Lyme Like Illness
* Typically the squeal of events begin with an Acute illness period (often viral or bacterial) then followed by intermittent but prolonged Chronic Fatigue Syndromes and migrating musculoskeletal joint symptoms eventually 'grumbling-on' to other forms of Neuro-Degenerative disorders.
Undersea Hyper Med. 2013 Mar-Apr;40(2):197-200.
The efficacy of hyperbaric oxygen therapy in the management of chronic fatigue syndrome
Gülhane Military Medical Academy Haydarpasa Training Hospital, Department of Physical Medicine and Rehabilitation, Istanbul, Turkey.
Chronic fatigue syndrome (CFS) is a chronic disease with social components that ensue secondary to the incapacity of the person to fulfill work, social and family responsibilities. Currently, there is no consensus regarding its treatment. The aim of this study was to determine the efficacy of hyperbaric oxygen (HBO2) therapy in CFS.
Sixteen patients included in the study were diagnosed with CFS according to the Fukuda criteria. Patients received 15 treatment sessions of HBO2 therapy over a period of three consecutive weeks (five days per week). The outcome measures (visual analog fatigue scale (VAFS). Fatigue Severity Scale (FSS) and Fatigue Quality of Life Score (FQLS) were assessed before the treatment and after completion of the 15 sessions.
HBO2 therapy was well tolerated, with no complications. After treatment, patients' scores were found to have improved with respect to VAFS, FSS and FQLS (all p<0.005).
We ,may infer that HBO2 therapy decreases the severity of symptoms and increases the life quality of CFS patients. It may be a new treatment modality for the management of CFS. However, further studies with larger sample sizes and control groups are definitely awaited.
Undersea Hyperb Med. 2012 Nov-Dec;39(6):1111-4.
Therapeutic effect of hyperbaric oxygen on inclusion body myositis
Philadelphia College of Osteopathic Medicine, Philadelphia, Pennsylvania, USA.
An inflammatory myopathy, inclusion body myositis (IBM) presents with progressive muscle weakness against a background of elevated creatine kinase and diffuse endomysial damage. Typically occurring in patients greater than 50 years of age, it is commonly misdiagnosed as polymyositis or other rheumatological disease and is often ineffectively treated with steroids . The approach to IBM is frequently a clinical challenge due to its unique and often aberrant response to common treatment modalities. Here we report an apparent improvement in the clinical course of and associated laboratory findings in a patient with co-existing IBM following the use of hyperbaric oxygen therapy as an adjunct for managing ischemic colitis.